|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12P 21/00 | |
| C12N 5/00 |
| (11) | Patento numeris | 2971036 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14715423.1 |
| Europos patento paraiškos padavimo data | 2014-03-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-01-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-02-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2014/059756 |
| Data | 2014-03-13 |
| (87) | Numeris | WO 2014/141151 |
| Data | 2014-09-18 |
| (30) | Numeris | Data | Šalis |
| 201361787105 P | 2013-03-15 | US |
| (72) |
LARA-VELASCO, Oscar, US
WAEHNER, Christina Michele, US
|
| (73) |
GlaxoSmithKline Intellectual Property (No. 2) Limited,
980 Great West Road, Brentford, Middlesex TW8 9GS,
GB
|
| (54) | USE OF TRICARBOXYLIC ACID (TCA) INTERMEDIATES TO CONTROL AMMONIA GENERATION IN CELL CULTURE |
| USE OF TRICARBOXYLIC ACID (TCA) INTERMEDIATES TO CONTROL AMMONIA GENERATION IN CELL CULTURE |